BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11438694)

  • 21. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
    Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
    Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
    Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
    Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cDNAs induced by the tumor suppressor Tsc2 gene using a conditional expression system in Tsc2 mutant (Eker) rat renal carcinoma cells.
    Orimoto K; Tsuchiya H; Sakurai J; Nishizawa M; Hino O
    Biochem Biophys Res Commun; 1998 Jun; 247(3):728-33. PubMed ID: 9647762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
    Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
    Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex.
    Zhang H; Nanba E; Yamamoto T; Ninomiya H; Ohno K; Mizuguchi M; Takeshita K
    J Hum Genet; 1999; 44(6):391-6. PubMed ID: 10570911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2.
    Lee-Jones L; Aligianis I; Davies PA; Puga A; Farndon PA; Stemmer-Rachamimov A; Ramesh V; Sampson JR
    Genes Chromosomes Cancer; 2004 Sep; 41(1):80-5. PubMed ID: 15236319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
    Kenerson HL; Aicher LD; True LD; Yeung RS
    Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germ-line Tsc2 mutation in a dominantly inherited cancer model defines a novel family of rat intracisternal-A particle elements.
    Xiao GH; Jin F; Yeung RS
    Oncogene; 1995 Jul; 11(1):81-7. PubMed ID: 7624135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
    Choi JE; Chae JH; Hwang YS; Kim KJ
    Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
    Nellist M; Burgers PC; van den Ouweland AM; Halley DJ; Luider TM
    Biochem Biophys Res Commun; 2005 Aug; 333(3):818-26. PubMed ID: 15963462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene.
    Honda S; Kobayashi T; Kajino K; Urakami S; Igawa M; Hino O
    Mol Carcinog; 2003 Jul; 37(3):122-9. PubMed ID: 12884363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.
    Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT
    PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis.
    Adachi H; Majima S; Kon S; Kobayashi T; Kajino K; Mitani H; Hirayama Y; Shiina H; Igawa M; Hino O
    Oncogene; 2004 Apr; 23(19):3495-500. PubMed ID: 14990989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple roles of the tuberous sclerosis complex genes.
    Yeung RS
    Genes Chromosomes Cancer; 2003 Dec; 38(4):368-75. PubMed ID: 14566857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic identification of a locus, Mot1, that affects renal tumor size in the rat.
    Yeung RS; Gu H; Lee M; Dundon TA
    Genomics; 2001 Dec; 78(3):108-12. PubMed ID: 11735216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pas1, a G1 cyclin, regulates amino acid uptake and rescues a delay in G1 arrest in Tsc1 and Tsc2 mutants in Schizosaccharomyces pombe.
    van Slegtenhorst M; Mustafa A; Henske EP
    Hum Mol Genet; 2005 Oct; 14(19):2851-8. PubMed ID: 16115814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M; Freilinger A; Lubec G; Hengstschläger M
    Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.